| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Andrew F Leuchter | |
| Ian A Cook | |||
| Aimee Hunter | |||
| Alex Korb | |||
| P2860 | cites work | Non-linear dynamic complexity of the human EEG during meditation | Q28201849 |
| Early changes in prefrontal activity characterize clinical responders to antidepressants | Q28204356 | ||
| Human anterior and frontal midline theta and lower alpha reflect emotionally positive state and internalized attention: high-resolution EEG investigation of meditation | Q28214498 | ||
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study | Q28259374 | ||
| Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder | Q28278505 | ||
| Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents | Q28307397 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice | Q29614979 | ||
| The number needed to treat: a clinically useful measure of treatment effect | Q29619672 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder | Q31121208 | ||
| When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment | Q32062833 | ||
| Validity of clinical trials of antidepressants | Q33852811 | ||
| Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome. | Q53015140 | ||
| Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. | Q53041522 | ||
| Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. | Q53899331 | ||
| Quantitative EEG in the prediction of antidepressant response to imipramine. | Q53984636 | ||
| Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. | Q54435147 | ||
| Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis | Q57042379 | ||
| Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. | Q33994367 | ||
| Medication augmentation after the failure of SSRIs for depression. | Q33994373 | ||
| The selectively distributed theta system: functions | Q34133306 | ||
| The National Comorbidity Survey Replication (NCS-R): background and aims. | Q34339246 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care | Q34578945 | ||
| Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication | Q34629048 | ||
| Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report | Q34658729 | ||
| White matter injury, neural connectivity and the pathophysiology of psychiatric disorders | Q35011657 | ||
| Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers | Q35901587 | ||
| The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder | Q36760626 | ||
| Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. | Q37120158 | ||
| The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings | Q37141888 | ||
| Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure | Q39420473 | ||
| Changes in brain function during administration of venlafaxine or placebo to normal subjects | Q40023174 | ||
| Expression, control, and probable functional significance of the neuronal theta-rhythm. | Q40453627 | ||
| Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis | Q40852012 | ||
| Cingulate cortex of the rhesus monkey: II. Cortical afferents | Q42523632 | ||
| Effect of primary care treatment of depression on service use by patients with high medical expenditures | Q42654113 | ||
| Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant | Q43556916 | ||
| Prefrontal changes and treatment response prediction in depression | Q43570723 | ||
| Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users | Q43752207 | ||
| Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression | Q44336402 | ||
| Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity | Q44652896 | ||
| Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects | Q44778317 | ||
| Electrophysiology of the frontal granular cortex. III. The cingulate-prefrontal relation in primate | Q44814272 | ||
| Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study | Q44817330 | ||
| Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder | Q45006432 | ||
| The economics of women and depression: an employer's perspective | Q45288872 | ||
| The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression | Q46497978 | ||
| Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function | Q46827847 | ||
| Relationship between brain electrical activity and cortical perfusion in normal subjects | Q48115664 | ||
| Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication | Q48161558 | ||
| Medial prefrontal cortex generates frontal midline theta rhythm | Q48234430 | ||
| Prediction of treatment response in major depression: integration of concepts | Q48415362 | ||
| Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study | Q48454595 | ||
| Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? | Q48603545 | ||
| Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats | Q48683420 | ||
| Cingulate function in depression: a potential predictor of treatment response | Q48768060 | ||
| Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis | Q48965818 | ||
| Disruption of early event-related theta synchronization of human EEG in alexithymics viewing affective pictures | Q51028382 | ||
| Continuity of antidepressant treatment for adults with depression in the United States. | Q51922693 | ||
| Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. | Q51939426 | ||
| Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. | Q51980792 | ||
| The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. | Q52970619 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| neurophysiology | Q660910 | ||
| P304 | page(s) | 78-83 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Clinical EEG and Neuroscience | Q15750908 |
| P1476 | title | Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence | |
| P478 | volume | 40 |
| Q47910495 | Alpha Wavelet Power as a Biomarker of Antidepressant Treatment Response in Bipolar Depression. |
| Q27307952 | Data mining EEG signals in depression for their diagnostic value |
| Q61448877 | Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical Data |
| Q30411170 | Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder |
| Q48317822 | QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder. |
| Q28267032 | Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect |
| Q48339743 | TMS by double-cone coil prefrontal stimulation for medication resistant chronic depression: a case report |
Search more.